发明名称 THERAPEUTIC FOR TREATING CLOSTRIDIUM DIFFICILE INFECTION
摘要 The invention relates to deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a pharmaceutical or veterinary composition or formulation comprising at least deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a combination therapeutic comprising at least deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a method of treating a mammal suspected of being infected with, or infected with, C. difficile comprising the use of at least deoxyribonuclease; a method of cleaning or sterilising a material or product comprising the use of at least deoxyribonuclease; and a cleaning or sterilising product impregnated with or containing at least deoxyribonuclease.
申请公布号 US2016058846(A1) 申请公布日期 2016.03.03
申请号 US201514932669 申请日期 2015.11.04
申请人 London School of Hygiene and Tropical Medicine 发明人 Dawson Lisa;Wren Brendan
分类号 A61K38/46;C11D3/48;A61L2/16;C11D3/386;A61K45/06;A61K38/48 主分类号 A61K38/46
代理机构 代理人
主权项 1. A method of treating a mammal suffering from a Clostridium difficile infection comprising administering to said mammal an effective amount of a deoxyribonuclease or a functional fragment thereof, thereby treating the Clostridium difficile infection.
地址 London GB